PROVIDENCE – Ocean Biomedical Inc. ended 2024 with a loss of $9.4 million compared to the $114.4 million deficit the company reported the year prior. In its annual report filed with the U.S. Securities and Exchange Commission on April 8, the biotech company said it has not generated any revenue since its inception in 2019.
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
